Alogliptin and Apixaban drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alogliptin (alogliptin benzoate) and Apixaban (apixaban). Common drug interactions include bradycardia among females and hyperkalaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Alogliptin and Apixaban. It is created by eHealthMe based on reports of 57 people who take the same drugs from the FDA, and is updated regularly.

What is Alogliptin?

Alogliptin has active ingredients of alogliptin benzoate. eHealthMe is studying from 1,943 Alogliptin users. Check the latest studies of Alogliptin.

What is Apixaban?

Apixaban has active ingredients of apixaban. It is often used in blood clots. eHealthMe is studying from 60,351 Apixaban users. Check the latest studies of Apixaban.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

57 people who take Alogliptin and Apixaban together, and have interactions are studied.

Alogliptin and Apixaban drug interactions.

What are the common drug interactions of Alogliptin and Apixaban, by gender? *:

female:

Bradycardia (abnormally slow heart action)
Cardiac arrest
Cellulitis (infection under the skin)
Hyperkalaemia (damage to or disease of the kidney)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Blood glucose increased
Gout (uric acid crystals building up in the body)
Malaise (a feeling of general discomfort or uneasiness)
Tumour haemorrhage (bleeding from tumour)
Thrombocytopenia (decrease of platelets in blood)

male:

Hyperkalaemia (damage to or disease of the kidney)
Circulatory collapse
Cardiac failure
Chest pain
Chronic kidney disease
Diabetic foot
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)

What are the common drug interactions of Alogliptin and Apixaban, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Thrombocytopenia (decrease of platelets in blood)

60+:

Hyperkalaemia (damage to or disease of the kidney)
Bradycardia (abnormally slow heart action)
Colon cancer
Retinal haemorrhage (bleeding from retina)
Vitreous detachment (a condition of the eye in which the vitreous humour separates from the retina)
Vitreous haemorrhage (intraocular (inside the eye) bleeding)
Abnormal loss of weight
Cardiac failure
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Chest pain

What are the existing conditions these people have? *

Type 2 Diabetes: 14 people, 24.56%
High Blood Pressure: 9 people, 15.79%
Diabetes: 6 people, 10.53%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 10.53%
Primary Myelofibrosis (primary disorder of the bone marrow): 5 people, 8.77%
Spinal Compression Fracture (fracture due to spinal compression on bone): 4 people, 7.02%
Rickets (softening of bones): 4 people, 7.02%
Iron Deficiency Anaemia: 4 people, 7.02%
Gout (uric acid crystals building up in the body): 4 people, 7.02%
Erection Problems: 4 people, 7.02%

* Approximation only. Some reports may have incomplete information.

Do you take Alogliptin and Apixaban?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously